Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Est. EPS: $10.54
Actual EPS: $9.47
EPS surprise: 6.24%
Company overview
Market Cap$69.7B
PriceUSD 664.52
P/E16.19
EPS (TTM)41.04
52-week high821.11
52-week low541.00
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410